Author

A. Vaccaro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Dimberg· 1 shared A. Jauslin· 1 shared A. S. Jakola· 1 shared A. Smits· 1 shared C. Bretz· 1 shared D. Leumann· 1 shared H. Huang· 1 shared I. Pietilä· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Dimberg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Reliable Particle Sizing in Vaccine Formulations using Advanced Dynamic LightScattering

C. Bretz, A. Jauslin, D. Leumann, M. Koch, A. Vaccaro

This paper demonstrates advanced dynamic light scattering technology that accurately measures particle size in vaccine formulations without sample dilution, overcoming multiple scattering artifacts.

bioRxiv · Mar 22, 2023Biophysics

Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma

L. van Hooren, A. Vaccaro, M. Ramachandran, K. Vazaios, S. Libard, T. van de Walle, M. Georganaki, H. Huang, I. Pietilä, J. Lau, M. H. Ulvmar, M. C. Karlsson, M. Zetterling, S. M. Mangsbo, A. S. Jakola, , A. Dimberg

This study shows that agonistic CD40 antibody therapy in glioma models causes T cell dysfunction and reduces response to checkpoint inhibitors, but also promotes tertiary lymphoid structures associated with improved T cell infiltration.

bioRxiv · Jan 5, 2021Cancer Biology